mda
Verificar en tripsit
MDA
Verificar en psychonaut
MDA
Verificar en isomerdesign
Tenamfetamine
Verificar en pubchem
Methylenedioxyamphet...
Verificar en drugmap
3,4-Methylenedioxyam...
Verificar en wiki
Data
InChI: InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3
Sinónimos: Amphedoxamine,AI3-24882, 1,3-Benzodioxole-5-ethanamine, alpha-methyl-, Tenamfetamina [Spanish], BRN 0150196,NCGC00168264-01,DEA No. 7400,EA-1299,SKF-5,1-(3,4-Methylenedioxyphenyl)-2-propylamine, Methylenedioxyamphetamine,.alpha.-Methyl-3,4-methylenedioxyphenethylamine, 4764-17-4,(+/-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,1,3-Benzodioxole-5-ethanamine, alpha-methyl-,(+/-)-.ALPHA.-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,1-(benzo[d][1,3]dioxol-5-yl)propan-2-amine,UNII-XJZ28FJ27W,DivK1c_000964,Tenamfetamine,1-(2H-1,3-benzodioxol-5-yl)propan-2-amine,CHEBI:166520,NINDS_000964,MDA,AKOS002433952,Tenamfetamine [INN],FT-0739487,(+/-)-MDA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Tenamfetamina,3,4-Methylenedioxyamphetamine,(S)-(+)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine,IDI1_000964,PDSP1_001410,3-(1,3-benzodioxol-5-yl)-1,1,1,2,3-pentadeuteriopropan-2-amine, 3,4-methylenedioxyamphetamine,1,3-Benzodioxole-5-ethanamine, alpha-methyl- (9CI),Tenamfetamina [Spanish], 1-(1,3-benzodioxol-5-yl)propan-2-amine, 3,4-Methylenedioxy-amphetamine,(-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,MDA (PSYCHEDELIC),3,4-Methylenedioxyamphetamine (MDA),MDA (pharmaceutical),Tenamfetaminum,(?)-alpha-Methyl-1,3-benzodioxole-5-(ethanamine),PDSP2_001394,4764-17-4,(R,S)-3,4-Methylenedioxyamphetamine,DB01509, MDA (pharmaceutical),DTXSID40859958,MDA, (R,S),1-(1,3-benzodioxol-5-yl)propan-2-amine, 5-19-08-00417 (Beilstein Handbook Reference),XJZ28FJ27W,(+)-alpha-Methyl-1,3-benzodioxole-5-(ethanamine),EA-1298,Love,TENAMFETAMINE [MART.],3,4-MDA,1,3-Benzodioxole,5-ethanamine-.alpha.-methyl-(.+/-.),Phenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-,CHEMBL6731,DS-015925,SCHEMBL393456, Tenamfetamine [INN], ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,BDBM50005247,(+/-)-3,4-(Methylenedioxy)amphetamine,BRN 0150196,MDA,R(-), alpha-Methyl-1,3-benzodioxole-5-ethanamine,MDA [MI], Phenethylamine, alp,rac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/ml in Methanol,5-19-08-00417 (Beilstein Handbook Reference), DEA No. 7400,(R)-(-)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,Phenethylamine, alpha-methyl-3,4-(methylenedioxy)-, AI3-24882,2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,alpha-Methyl-3,4-methylenedioxyphenethylamine,ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,TENAMFETAMINE [WHO-DD],2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine((R)-(-)-MDA),Methylenedioxyamphetamine,alpha-Methyl-1,3-benzodioxole-5-ethanamine,DL-alpha-Methyl-3,4-(methylenedioxy)phenylethylamine,.alpha.-Methyl-3,4-(methylenedioxy)phenethylamine, CHEMBL6731,51497-09-7,rac-3,4-Methylenedioxyamphetamine,3,4-Methylenedioxy-amphetamine,HSDB 7593,1-Benzo[1,3]dioxol-5-ylpropan-2-amine,methylene dioxyamphetamine,KBio1_000964, Tenamfetaminum [Latin],5-(2-Aminopropyl)-1,3-benzodioxole,1,3-Benzodioxole-5-ethanamine, .alpha.-methyl-,3,4-(Methylenedioxy)-alpha-methylphenylethylamine,3,4-methylenedioxyamphetamine, NGBBVGZWCFBOGO-UHFFFAOYSA-N,Q223020,Tenamfetaminum [Latin]
Estimated data
Solubilidad: -1.476 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 94.1% (prediction based on www.mdpi.com)
